[Clinical practice of systemic lysis in prehospital resuscitation. Success and complication rates].
Medizinische Klinik - Intensivmedizin und Notfallmedizin · 2015-02-14 · Observational study
Abstract
BACKGROUND: Systemic thrombolysis was introduced as the sole prehospital treatment option in patients with cardiac arrest in the setting of acute myocardial ischemia or pulmonary embolism; however, it remains the subject of discussion. PATIENTS AND METHODS: A total of 194 patients with sudden prehospital cardiac arrest were included in this retrospective case control study. Of these patients, 96 in whom circulatory arrest due to cardiac disease (pulmonary artery embolism or myocardial ischemia) was suspected underwent thrombolytic treatment and were compared to the remaining 98 patients that did not undergo thrombolytic therapy. In addition to the circumstances of circulatory arrest, the course and success of resuscitation, as well as in-hospital course (including bleeding complications), overall survival and neurological outcomes were compared. RESULTS: There were no significant differences between patients with or without thrombolysis in terms of the circumstances of cardiac arrest. Patients that received thrombolytic treatment were significantly younger and were more frequently treated with anticoagulants, platelet aggregation inhibitors and amiodarone. They also received higher doses of epinephrine and arrived at hospital under ongoing resuscitation significantly more frequently. A trend toward more prehospital return of spontaneous circulation (ROSC) following thrombolytic treatment was seen in the entire cohort. However, patients pre-treated with acetylsalicylic acid and heparin did not show better prehospital ROSC rates as a result of additional thrombolytic therapy. Significant differences in terms of bleeding complications or the need for blood transfusion could not be seen due to the small number of patients. DISCUSSION: The indication for systemic thrombolysis in the context of prehospital resuscitation should remain restricted to patients with clear symptoms of acute pulmonary embolism or recurrent episodes of ventricular fibrillation in the setting of acute myocardial infarction. Due to a lack of evidence, systemic thrombolysis should not be used as a treatment of last resort in younger patients with persistent ventricular fibrillation.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Mortality & survival · Quality of life & function · Thrombolytics
Related articles
- ["Highlights" in emergency medicine -- severe head trauma, polytrauma and cardiac arrest]. (Anasthesiol Intensivmed Notfallmed Schmerzther, 2005)
- International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. (Eur J Clin Invest, 2005)
- Intra-arrest systemic thrombolytic therapy during cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled trials. (Resusc Plus, 2026)
- Familial pulmonary embolism in two siblings with first presentation as sudden cardiac arrest: a clinical case report from the Indian subcontinent. (Int J Emerg Med, 2026)
- Thrombolytics in CPR. Current advantages in cardiopulmonary resuscitation. (Minerva Anestesiol, 2005)
- Thrombolysis during resuscitation for out-of-hospital cardiac arrest. (N Engl J Med, 2008)